Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function

PURPOSE: Revefenacin, a long-acting muscarinic antagonist for nebulization, has been shown to improve lung function in patients with chronic obstructive pulmonary disease. Here we report pharmacokinetic (PK) and safety results from two multicenter, open-label, single-dose trials evaluating revefenac...

Descripción completa

Detalles Bibliográficos
Autores principales: Borin, Marie T, Lo, Arthur, Barnes, Chris N, Pendyala, Srikanth, Bourdet, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790214/
https://www.ncbi.nlm.nih.gov/pubmed/31632000
http://dx.doi.org/10.2147/COPD.S203709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790214/
https://www.ncbi.nlm.nih.gov/pubmed/31632000
http://dx.doi.org/10.2147/COPD.S203709

Ejemplares similares